China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 75 full-time employees. The company went IPO on 2019-01-04. The firm sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The firm sells its products under the brand Suxuantang.
SXTC stock price ended at $2.61 on 星期五, after dropping 0.76%
On the latest trading day Feb 13, 2026, the stock price of SXTC fell by 0.76%, dropping from $2.53 to $2.61. During the session, the stock saw a volatility of 16.47%, with prices oscillating between a daily low of $2.49 and a high of $2.90. On the latest trading day, the trading volume for SXTC rose by 102.7K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 243.4K shares were traded, with a market value of approximately $302.8M.